WallStreetZenWallStreetZen

NYSE: TARO
Taro Pharmaceutical Industries Ltd Stock

$42.26+0.12 (+0.28%)
Updated Mar 27, 2024
TARO Price
$42.26
Fair Value Price
N/A
Market Cap
$1.59B
52 Week Low
$22.89
52 Week High
$45.76
P/E
34.64x
P/B
0.89x
P/S
2.57x
PEG
N/A
Dividend Yield
N/A
Revenue
$610.83M
Earnings
$45.70M
Gross Margin
48%
Operating Margin
12.17%
Profit Margin
7.5%
Debt to Equity
0.22
Operating Cash Flow
N/A
Beta
0.46
Next Earnings
May 21, 2024
Ex-Dividend
N/A
Next Dividend
N/A

TARO Overview

Taro Pharmaceutical Industries Limited manufactures and markets prescription and over-the-counter drugs covering various therapeutic categories in the U.S. and internationally. It provides its products as capsules, creams, drops, emulsions, gels/gel kits, granules, injectables, oils, ointments,powders for solution, suppositories, solutions for infusion, sprays, suspensions, and syrups. Taro Pharmaceutical was founded in 1950 and is based in Haifa, Israel.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TARO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TARO was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TARO is good value based on its earnings relative to its share price (34.64x), compared to the US market average (44.45x)
P/E vs Market Valuation
TARO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more TARO due diligence checks available for Premium users.

Be the first to know about important TARO news, forecast changes, insider trades & much more!

TARO News

Valuation

TARO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
34.64x
Industry
53.92x
Market
44.45x
TARO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TARO is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

TARO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.89x
Industry
2.2x
TARO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TARO's financial health

Profit margin

Revenue
$157.1M
Net Income
$20.2M
Profit Margin
12.9%
TARO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.2B
Liabilities
$384.1M
Debt to equity
0.22
TARO's short-term assets ($1.35B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TARO's short-term assets ($1.35B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TARO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
TARO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$30.9M
Investing
$81.7M
Financing
$0.0

TARO vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
TARO$1.59B+0.28%34.64x0.89x
DVAX$1.62B+0.32%-248.20x2.61x
AVDL$1.53B+3.69%-8.42x17.38x
ANIP$1.47B+0.20%81.03x3.39x
PCRX$1.35B+1.86%31.91x1.55x

Taro Pharmaceutical Industries Stock FAQ

What is Taro Pharmaceutical Industries's quote symbol?

(NYSE: TARO) Taro Pharmaceutical Industries trades on the NYSE under the ticker symbol TARO. Taro Pharmaceutical Industries stock quotes can also be displayed as NYSE: TARO.

If you're new to stock investing, here's how to buy Taro Pharmaceutical Industries stock.

What is the 52 week high and low for Taro Pharmaceutical Industries (NYSE: TARO)?

(NYSE: TARO) Taro Pharmaceutical Industries's 52-week high was $45.76, and its 52-week low was $22.89. It is currently -7.65% from its 52-week high and 84.62% from its 52-week low.

How much is Taro Pharmaceutical Industries stock worth today?

(NYSE: TARO) Taro Pharmaceutical Industries currently has 37,587,231 outstanding shares. With Taro Pharmaceutical Industries stock trading at $42.26 per share, the total value of Taro Pharmaceutical Industries stock (market capitalization) is $1.59B.

Taro Pharmaceutical Industries stock was originally listed at a price of $2.72 in Dec 31, 1997. If you had invested in Taro Pharmaceutical Industries stock at $2.72, your return over the last 26 years would have been 1,453.68%, for an annualized return of 11.13% (not including any dividends or dividend reinvestments).

How much is Taro Pharmaceutical Industries's stock price per share?

(NYSE: TARO) Taro Pharmaceutical Industries stock price per share is $42.26 today (as of Mar 27, 2024).

What is Taro Pharmaceutical Industries's Market Cap?

(NYSE: TARO) Taro Pharmaceutical Industries's market cap is $1.59B, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Taro Pharmaceutical Industries's market cap is calculated by multiplying TARO's current stock price of $42.26 by TARO's total outstanding shares of 37,587,231.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.